Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 7Recruiting 5Unknown 3Active not recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Pancreatic Intraductal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Acinar Cell 1

Interventions

pembrolizumab 439Carboplatin 323Nivolumab 291Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 254Paclitaxel 249Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 169atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Radiosurgery 114Oxaliplatin 114Pemetrexed 113Etoposide 111Fluorouracil 110venetoclax 108fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Pancreatectomy × Clear all
NCT04594772 2026-06-01

Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma

University of Cincinnati

Phase 2 Active not recruiting
32 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02757859 2026-05-29

WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer

Thomas Jefferson University

Phase NA Active not recruiting
845 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Carcinoma, Acinar Cell, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡